Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Analgesic and anti-inflammatory properties of aqueous extract of Deverra scoparia Coss and Dur obtained from Tamanrasset, Algeria

Lilya Harchaoui , Djamila Chabane, Saida Ouafi

Research Laboratory on Arid Zones (LRZA) Faculty of Biological Sciences, University of Sciences and Technology Houari Boumediene (USTHB), Algiers, Algeria;

For correspondence:-  Lilya Harchaoui   Email: lilya.h@live.fr   Tel:+21321467539

Accepted: 17 July 2018        Published: 31 August 2018

Citation: Harchaoui L, Chabane D, Ouafi S. Analgesic and anti-inflammatory properties of aqueous extract of Deverra scoparia Coss and Dur obtained from Tamanrasset, Algeria. Trop J Pharm Res 2018; 17(8):1523-1529 doi: 10.4314/tjpr.v17i8.9

© 2018 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To determine the toxicity, anti-inflammatory and analgesic properties of Deverra scoparia Coss. & Dur. and the phenolic compounds involved
Methods: The aqueous extract of Deverra scoparia Coss. & Dur. was intra-gastrically administered at increasing  doses (2, 4, 8, 12 and 16 g/kg) to mice of both sexes in order to study its acute toxicity. Analgesic activity was evaluated in mice and rats using acetic acid-induced writhing and formalin tests at doses of 250, 500 and 1000 mg/kg. Anti-inflammatory activity was assessed by carrageenan-induced paw oedema method, while the bioactive compounds in the extract were identified by high performance liquid chromatography (HPLC) analysis.
Results: The extract (1000 mg/kg) produced significant inhibition in acetic acid-induced writhing (71.18 %) and formalin (83.58 %) tests; and 73.52 % reduction of carrageenan-induced rat paw oedema test (p < 0.001). HPLC analysis revealed the presence of two phenolic acids, viz, salicylic acid (21.81 mg/g dry weight) and rosmarinic acid (28.44 mg/g dry weight); and apigenin, a flavonoid aglycone (5.70 mg/g dry weight).
Conclusion: These results indicate that the extract of Deverra scoparia Coss. & Dur. is non-toxic even at a dose of 16g/kg. The extract possesses significant analgesic and anti-inflammatory potential which may be due to the presence of phenolic compounds (apigenin, salicylic acid and rosmarinic acid.

Keywords: Deverra scoparia Coss. & Dur., Acute toxicity, Anti-inflammatory, Analgesic, HPLC, Phenolic compounds

Impact Factor
Thompson Reuters (ISI): 0.6 (2023)
H-5 index (Google Scholar): 49 (2023)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal:

Archives

2024; 23: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10
2023; 22: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2022; 21: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2021; 20: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2020; 19: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2019; 18: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2018; 17: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2017; 16: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2016; 15: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2015; 14: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2014; 13: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2013; 12: 
1,   2,   3,   4,   5,   6
2012; 11: 
1,   2,   3,   4,   5,   6
2011; 10: 
1,   2,   3,   4,   5,   6
2010; 9: 
1,   2,   3,   4,   5,   6
2009; 8: 
1,   2,   3,   4,   5,   6
2008; 7: 
1,   2,   3,   4
2007; 6: 
1,   2,   3,   4
2006; 5: 
1,   2
2005; 4: 
1,   2
2004; 3: 
1
2003; 2: 
1,   2
2002; 1: 
1,   2

News Updates